Pfizer’s vaccine, the second to get FDA approval for RSV, is more than 85 percent effective at preventing severe disease caused by the common respiratory syncytial virus.
A roundup of some of the most popular but completely untrue stories and visuals of the week. None of these are legit, even though they were shared widely on social media. The Associated Press checked them out. Here are the facts: